hyaluronoglucosaminidase has been researched along with pentoxifylline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shumskiĭ, AV | 1 |
| Goldman, MP; Kiken, DA | 1 |
| António, NN; Marques, RG; Monte Alto Costa, A | 1 |
| Srivastava, R; Wazir, SS | 1 |
4 other study(ies) available for hyaluronoglucosaminidase and pentoxifylline
| Article | Year |
|---|---|
[Lymphotropic therapy with trental in the treatment of chronic herpetic stomatitis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibody Formation; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Humans; Hyaluronoglucosaminidase; Immunity, Cellular; Immunity, Innate; Injections, Intralymphatic; Naphthoquinones; Pentoxifylline; Stomatitis, Herpetic | 1997 |
Inadvertent injection of sodium tetradecyl sulfate during placement of mental nerve block: discussion of management and outcome.
Topics: Adult; Biocompatible Materials; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Hyperbaric Oxygenation; Injections; Intraoperative Complications; Necrosis; Nerve Block; Pentoxifylline; Peripheral Nerves; Peripheral Nervous System Diseases; Saline Solution, Hypertonic; Sclerosing Solutions; Skin Diseases; Sodium Tetradecyl Sulfate; Vasodilator Agents | 2009 |
Viability of randomized skin flaps-an experimental study in rats.
Topics: Animals; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Hyaluronoglucosaminidase; Injections, Intralesional; Male; Necrosis; Pentoxifylline; Phosphodiesterase Inhibitors; Postoperative Complications; Protective Agents; Random Allocation; Rats; Rats, Wistar; Skin; Surgical Flaps; Treatment Outcome | 2017 |
Pentoxifylline - A Novel Adjunct in the Management of Patients with Oral Submucous Fibrosis in Terai Population of Nepal: A Prospective Case Control Study.
Topics: Anti-Inflammatory Agents; Case-Control Studies; Dexamethasone; Humans; Hyaluronoglucosaminidase; Lidocaine; Nepal; Oral Submucous Fibrosis; Pentoxifylline | 2022 |